BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 25141071)

  • 1. Budesonide for maintenance of remission in Crohn's disease.
    Kuenzig ME; Rezaie A; Seow CH; Otley AR; Steinhart AH; Griffiths AM; Kaplan GG; Benchimol EI
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD002913. PubMed ID: 25141071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Budesonide for maintenance of remission in Crohn's disease.
    Benchimol EI; Seow CH; Otley AR; Steinhart AH
    Cochrane Database Syst Rev; 2009 Jan; (1):CD002913. PubMed ID: 19160212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budesonide for induction of remission in Crohn's disease.
    Rezaie A; Kuenzig ME; Benchimol EI; Griffiths AM; Otley AR; Steinhart AH; Kaplan GG; Seow CH
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD000296. PubMed ID: 26039678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral budesonide for induction of remission in ulcerative colitis.
    Sherlock ME; MacDonald JK; Griffiths AM; Steinhart AH; Seow CH
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD007698. PubMed ID: 26497719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminosalicylates for induction of remission or response in Crohn's disease.
    Lim WC; Wang Y; MacDonald JK; Hanauer S
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD008870. PubMed ID: 27372735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
    Gordon M; Taylor K; Akobeng AK; Thomas AG
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD010233. PubMed ID: 25081347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
    Chande N; Patton PH; Tsoulis DJ; Thomas BS; MacDonald JK
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD000067. PubMed ID: 26517527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics for induction and maintenance of remission in Crohn's disease.
    Townsend CM; Parker CE; MacDonald JK; Nguyen TM; Jairath V; Feagan BG; Khanna R
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012730. PubMed ID: 30731030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate for maintenance of remission in Crohn's disease.
    Patel V; Wang Y; MacDonald JK; McDonald JW; Chande N
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD006884. PubMed ID: 25157445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis for the treatment of Crohn's disease.
    Kafil TS; Nguyen TM; MacDonald JK; Chande N
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012853. PubMed ID: 30407616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Wang Y; Tsoulis DJ; MacDonald JK; Feagan BG
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD003459. PubMed ID: 25099640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Budesonide for induction of remission in Crohn's disease.
    Seow CH; Benchimol EI; Griffiths AM; Otley AR; Steinhart AH
    Cochrane Database Syst Rev; 2008 Jul; (3):CD000296. PubMed ID: 18646064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tuberculous therapy for maintenance of remission in Crohn's disease.
    Patton PH; Parker CE; MacDonald JK; Chande N
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD000299. PubMed ID: 27444319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adalimumab for maintenance of remission in Crohn's disease.
    Townsend CM; Nguyen TM; Cepek J; Abbass M; Parker CE; MacDonald JK; Khanna R; Jairath V; Feagan BG
    Cochrane Database Syst Rev; 2020 May; 5(5):CD012877. PubMed ID: 32413933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enteral nutrition for maintenance of remission in Crohn's disease.
    Akobeng AK; Zhang D; Gordon M; MacDonald JK
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD005984. PubMed ID: 30098021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease.
    Boyapati RK; Torres J; Palmela C; Parker CE; Silverberg OM; Upadhyaya SD; Nguyen TM; Colombel JF
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012540. PubMed ID: 29756637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N; Townsend CM; Parker CE; MacDonald JK
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD000545. PubMed ID: 27783843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N; Tsoulis DJ; MacDonald JK
    Cochrane Database Syst Rev; 2013 Apr; (4):CD000545. PubMed ID: 23633304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease.
    Khanna R; Preiss JC; MacDonald JK; Timmer A
    Cochrane Database Syst Rev; 2015 May; (5):CD007572. PubMed ID: 25942580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.